These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 31386765

  • 1. Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity.
    Bentata Y.
    Artif Organs; 2020 Feb; 44(2):140-152. PubMed ID: 31386765
    [Abstract] [Full Text] [Related]

  • 2. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ, PʼNg CH, OʼConnell PJ, Chapman JR.
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [Abstract] [Full Text] [Related]

  • 3. Two Decades of Tacrolimus in Renal Transplant: Basic Science and Clinical Evidences.
    Shrestha BM.
    Exp Clin Transplant; 2017 Feb; 15(1):1-9. PubMed ID: 27938316
    [Abstract] [Full Text] [Related]

  • 4. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T, Omoto K, Shimizu T, Ishida H, Tanabe K.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
    [Abstract] [Full Text] [Related]

  • 5. High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime.
    Whalen HR, Glen JA, Harkins V, Stevens KK, Jardine AG, Geddes CC, Clancy MJ.
    Transplantation; 2017 Feb; 101(2):430-436. PubMed ID: 26950724
    [Abstract] [Full Text] [Related]

  • 6. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK, Wu FL, Lai IR, Lee CY, Hu RH, Lee PH.
    Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
    [Abstract] [Full Text] [Related]

  • 7. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B, Höcker B.
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [Abstract] [Full Text] [Related]

  • 8. Calcineurin Inhibitor-Sparing Strategies in Renal Transplantation: Where Are We? A Comprehensive Review of the Current Evidence.
    Camilleri B, Bridson JM, Halawa A.
    Exp Clin Transplant; 2016 Oct; 14(5):471-483. PubMed ID: 27213490
    [Abstract] [Full Text] [Related]

  • 9. Late conversion from tacrolimus to a belatacept-based immuno-suppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism.
    Schulte K, Vollmer C, Klasen V, Bräsen JH, Püchel J, Borzikowsky C, Kunzendorf U, Feldkamp T.
    J Nephrol; 2017 Aug; 30(4):607-615. PubMed ID: 28540602
    [Abstract] [Full Text] [Related]

  • 10. Comparison of tacrolimus and cyclosporine for immunosuppression after renal transplantation: An updated systematic review and meta-analysis.
    Azarfar A, Ravanshad Y, Mehrad-Majd H, Esmaeeli M, Aval SB, Emadzadeh M, Salehi M, Moradi A, Golsorkhi M, Khazaei MR.
    Saudi J Kidney Dis Transpl; 2018 Aug; 29(6):1376-1385. PubMed ID: 30588970
    [Abstract] [Full Text] [Related]

  • 11. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
    Nair SS, Sarasamma S, Gracious N, George J, Anish TS, Radhakrishnan R.
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus Intrapatient Variability on Graft Outcomes in Adherent Renal Transplantation Patients: A Cross-Sectional Study.
    Nafar M, Keshtkari S, Ziaie S, Firouzan A, Borumandnia N, Dalili N, Poorrezagholi F, Samadian F, Samavat S.
    Iran J Kidney Dis; 2024 May; 18(3):187-194. PubMed ID: 38904339
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Calcineurin inhibitor nephrotoxicity.
    Naesens M, Kuypers DR, Sarwal M.
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):481-508. PubMed ID: 19218475
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Limitations of current liver transplant immunosuppressive regimens: renal considerations.
    Zhang W, Fung J.
    Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):27-32. PubMed ID: 28119255
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium.
    Jacobson PA, Schladt D, Israni A, Oetting WS, Lin YC, Leduc R, Guan W, Lamba V, Matas AJ, DeKAF Investigators.
    Transplantation; 2012 Mar 27; 93(6):624-31. PubMed ID: 22334041
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.